It is the 100% Efficiency version of the Pfaffl Ratio Method in the Chapter 3 I sent.
Also see the attached Excel file.
The trick is knowing in which order to subtract the Ct values in the exponent part of the equation. If you subtract Control Ct from Treated Ct or if you subtract Treated Ct from Control Ct; you get the reciprocal result. One is considered fold down regulation, while its inverse is considered up-regulation. It's all a matter of being in control of and aware of which way you flip the fraction (e.g., which way you subtract the exponent Ct values; since when you log values that are subtracted, that implies division by mathematic principle) ... likewise when you add exponents, that implies multiplication by basic log rules as well.
See the attached Excel file for clarification.
You are performing a "delta Ct" method when normalizing to a reference gene.
And, when you divide this result by a control ("calibrator") sample target level already normalized to its respective GA3PDH level, then you are performing a "delta delta Ct method". E.g. 2 to the -delta delta Ct or the efficiency corrected Pfaffl Ratio Method (which are identical methods when all Eamp values = 2 (e.g. all target and ref genes are assumed to amplify at 100% efficiency). See attached.
You can find a link to a free PDF of this article when you google for "Livak_Schmittgen2001.pdf" under dingo.ucsf.edu/twiki/.../Livak_Schmittgen2001.pdf.
You may want to use the comparative Ct method, it´s easy to understand. I recommend you to download "Guide to Performing Relative Quantitation of Gene Expression Using Real-Time Quantitative PCR", of Applied Biosystems. In section VII, you have everything you need to start doing your calculations for relative quantitation.
In that case, Jochen, you are right. Thus, I suggest to do simply the same calculations with the concentrations values of gene X and GAPDH to obtain the fold change.
It is the 100% Efficiency version of the Pfaffl Ratio Method in the Chapter 3 I sent.
Also see the attached Excel file.
The trick is knowing in which order to subtract the Ct values in the exponent part of the equation. If you subtract Control Ct from Treated Ct or if you subtract Treated Ct from Control Ct; you get the reciprocal result. One is considered fold down regulation, while its inverse is considered up-regulation. It's all a matter of being in control of and aware of which way you flip the fraction (e.g., which way you subtract the exponent Ct values; since when you log values that are subtracted, that implies division by mathematic principle) ... likewise when you add exponents, that implies multiplication by basic log rules as well.
See the attached Excel file for clarification.
You are performing a "delta Ct" method when normalizing to a reference gene.
And, when you divide this result by a control ("calibrator") sample target level already normalized to its respective GA3PDH level, then you are performing a "delta delta Ct method". E.g. 2 to the -delta delta Ct or the efficiency corrected Pfaffl Ratio Method (which are identical methods when all Eamp values = 2 (e.g. all target and ref genes are assumed to amplify at 100% efficiency). See attached.